FLGT Q3 2023 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q3 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$85M-19.8% YoY

Gross Profit

$40M47.0% margin

Operating Income

$214,0000.3% margin

Net Income

-$13M-15.5% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

+24.8%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$5M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$97M

Stockholders' Equity

$1.3B

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$85M	$106M	-19.8%
Gross Profit	$40M	$46M	-13.6%
Operating Income	$214,000	$352,000	-39.2%
Net Income	-$13M	$2M	-862.5%

Geographic Segments

UNITED STATES

$79M93%

Non-US

$6M7%